Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 118 (RPL21P118) is a non-coding DNA sequence found in the human genome and classified as a pseudogene. It shares homology with the functional ribosomal protein L21 gene (RPL21) but does not encode a protein and has no known biological, clinical, or therapeutic significance. Pseudogenes such as RPL21P118 are vestigial remnants of gene evolution and are typically not transcribed or translated.
None (no action mechanism is assigned to this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 118 (RPL21P118).